458
Views
24
CrossRef citations to date
0
Altmetric
Articles

The pathology of eclampsia: An autopsy series

, , , , , & show all
Pages 259-268 | Received 16 Mar 2017, Accepted 07 May 2017, Published online: 05 Jul 2017

References

  • Duley L. The Global Impact of Pre-Eclampsia and Eclampsia, Semin. Perinatol. 2009:33:130–137.
  • Powe CE, Levine RJ, and Karumanchi SA. Preeclampsia, A Disease of the Maternal Endothelium: The Role of Antiangiogenic Factors and Implications for Later Cardiovascular Disease, Circulation. 2011:123:2856–2869.
  • Hod T, Cerdeira AS, and Karumanchi SA. Molecular Mechanisms of Preeclampsia, Cold Spring Harbor Perspect. Med. 2015;5:a023473.
  • Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, and Group CS. Soluble Endoglin and other Circulating Antiangiogenic Factors in Preeclampsia, N. Engl. J. Med. 2006:355:992–1005.
  • Vaisbuch E, Whitty JE, Hassan SS, Romero R, Kusanovic JP, Cotton DB, Sorokin Y, and Karumanchi SA. Circulating Angiogenic and Antiangiogenic Factors in Women with Eclampsia, Am. J. Obstetrics Gynecol. 2011:204:152 e1–e9.
  • Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D’Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M,and Karumanchi SA. Soluble Endoglin Contributes to the Pathogenesis of Preeclampsia, Nat. Med. 2006:12:642–649.
  • Roberts JM and Hubel CA. Oxidative Stress in Preeclampsia, Am. J. Obstetrics Gynecol. 2004:190:1177–1178.
  • Sheehan HL and Lynch JB. Pathology of Toxaemia of Pregnancy. Williams and Wilkins Company, Baltimore, 1973.
  • Menendez C, Romagosa C, Ismail MR, Carrilho C, Saute F, Osman N, Machungo F, Bardaji A, Quinto L, Mayor A, Naniche D, Dobano C, Alonso PL, and Ordi J. An Autopsy Study of Maternal Mortality in Mozambique: The Contribution of Infectious Diseases, PLoS Med. 2008:5:e44.
  • Hecht JL, Zsengeller ZK, Spiel M, Karumanchi SA, and Rosen S. Revisiting Decidual Vasculopathy, Placenta. 2016:42:37–43.
  • Schwartz RB, Feske SK, Polak JF, DeGirolami U, Iaia A, Beckner KM, Bravo SM, Klufas RA, Chai RY, and Repke JT. Preeclampsia-Eclampsia: Clinical and Neuroradiographic Correlates and Insights into the Pathogenesis of Hypertensive Encephalopathy, Radiology. 2000:217:371–376.
  • Stillman IE and Karumanchi SA. The Glomerular Injury of Preeclampsia, J. Am. Soc. Nephrol.: JASN. 2007:18:2281–2284.
  • Antia FP, Bharadwaj TP, Watsa MC and Master J. Liver in Normal Pregnancy, Pre-eclampsia, and Eclampsia, Lancet. 1958:2:776–778.
  • Tsokos M, Longauer F, Kardosova V, Gavel A, Anders S, and Schulz F. Maternal Death in Pregnancy from HELLP Syndrome. A Report of Three Medico-Legal Autopsy Cases with Special Reference to Distinctive Histopathological Alterations, Int. J. Legal Med. 2002:116:50–53.
  • Long RG, Scheuer PJ, and Sherlock S. Pre-Eclampsia Presenting with Deep Jaundice, J. Clin. Pathol. 1977:30:212–215.
  • Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, and Karumanchi SA. Excess Placental Soluble Fms-Like Tyrosine Kinase 1 (sFlt1) May Contribute to Endothelial Dysfunction, Hypertension, and Proteinuria in Preeclampsia, J. Clin. Invest. 2003:111:649–658.
  • McCarthy FP, Kingdom JC, Kenny LC, and Walsh SK. Animal Models of Preeclampsia; Uses and Limitations, Placenta. 2011:32:413–419.
  • Mahasreshti PJ, Kataram M, Wang MH, Stockard CR, Grizzle WE, Carey D, Siegal GP, Haisma HJ, Alvarez RD, and Curiel DT. Intravenous Delivery of Adenovirus-Mediated Soluble FLT-1 Results in Liver Toxicity, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 2003:9:2701–2710.
  • Abildgaard U and Heimdal K. Pathogenesis of the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count (HELLP): A Review, Eur. J. Obstet. Gynecol. Reprod. Biol. 2013:166:117–123.
  • Govan AD. The Histology of Eclamptic Lesions, J. Clin. Pathol. Suppl. 1976:10:63–69.
  • Iwakiri Y, Shah V, and Rockey DC. Vascular Pathobiology in Chronic Liver Disease and Cirrhosis - Current Status and Future Directions. J. Hepatol. 2014:61:912–924.
  • Lazarus A and Keshet E. Vascular Endothelial Growth Factor and Vascular Homeostasis, Proc. Am. Thoracic Soc. 2011:8:508–511.
  • Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC, Matharu KS, Karumanchi SA, and D’Amore PA. VEGF and TGF-beta are Required for the Maintenance of the Choroid Plexus and Ependyma, J. Exp. Med. 2008:205:491–501.
  • Brown LF, Berse B, Tognazzi K, Manseau EJ, Van de Water L, Senger DR, Dvorak HF, and Rosen S. Vascular Permeability Factor mRNA and Protein Expression in Human Kidney, Kidney Int. 1992:42:1457–1461.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.